The global decrease in cancer mortality: trends and disparities
D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri, D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri
Abstract
Background: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear.
Design: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate.
Results: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'.
Conclusions: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
Keywords: cancer; data collection/standards; global health; mortality; registries/standards; vital statistics.
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Source: PubMed
Kommende kliniske studier
-
NCT07680075Har ikke rekruttert ennåMotor ferdigheter | Sunn | Utøvende funksjon
-
NCT07680088Har ikke rekruttert ennåAnal plateepitelkarsinom
-
NCT07680101Har ikke rekruttert ennåLeddgikt | Degenerativ leddsykdom i kne
-
NCT07680114Har ikke rekruttert ennå
-
NCT07680127Har ikke rekruttert ennåCerebralt ødem | Strålingsnekrose
-
NCT07680140Har ikke rekruttert ennåKetamin | fMRI | Depresjon - alvorlig depressiv lidelse | rTMS | Behandlingsresistent depresjon (TRD)
-
NCT07680153Har ikke rekruttert ennåfMRI | Bipolar lidelse (BD) | rTMS | Bipolar 1 depresjon
-
NCT07680166Har ikke rekruttert ennå
-
NCT07680179Har ikke rekruttert ennåSelvmord | Selvmordsforebygging
-
NCT07680205RekrutteringFeokromocytom | Feokromocytom/Paragangliom | Feokromocytom, metastatisk | Feokromocytom ondartet | Pheokromocytom og paraganglioma (PPGL)
-
NCT07680244RekrutteringEpiretinal membran | Retina sykdom | Tørr aldersrelatert makuladegenerasjon | Vitreoretinal abnormitet | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal Pigment Epithelium (RPE) Atrophy
-
NCT07680257Rekruttering